Esprinet S.p.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 3,985.16 million compared to EUR 4,684.16 million a year ago. Net loss was EUR 11.88 million compared to net income of EUR 47.35 million a year ago.

Basic loss per share from continuing operations was EUR 0.24 compared to basic earnings per share from continuing operations of EUR 0.96 a year ago. Diluted loss per share from continuing operations was EUR 0.24 compared to diluted earnings per share from continuing operations of EUR 0.95 a year ago.